Search results for "Risk Factor"

showing 10 items of 4321 documents

Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe

2013

Objective Scanty information is available on the clinical characteristics of resistant hypertension in Central and East European countries. The Blood Pressure (BP) control rate and CArdiovascular Risk profilE (BP-CARE) study allowed us to assess the prevalence and the main clinical features of resistant hypertension in this population. Design and method The study was carried out in 1312 treated hypertensive patients living in nine Central and East European countries. Results Four hundred and twenty-three patients had apparent resistant hypertension, of whom 168 had pseudo-resistant hypertension (noncompliant/white-coat) and 255 were true treatment-resistant hypertension patients (TRH). Clin…

AdultMalemedicine.medical_specialtyAmbulatory blood pressurePhysiologyCross-sectional studyPopulationDrug ResistanceRenal functionBlood PressureBody Mass IndexRisk FactorsInternal medicinePrevalenceInternal MedicinemedicineHumansEurope EasternObesityRenal InsufficiencyeducationAntihypertensive AgentsAgededucation.field_of_studybusiness.industryresistant hypertensionBlood Pressure DeterminationMiddle Agedmedicine.diseaseObesityCross-Sectional StudiesTreatment OutcomeEndocrinologyBlood pressureCardiovascular DiseasesHeart failureHypertensionFemaleCardiology and Cardiovascular MedicinebusinessBody mass indexWhite Coat HypertensionGlomerular Filtration RateJournal of Hypertension
researchProduct

Ambulatory Arterial Stiffness Index (AASI) is Unable to Estimate Arterial Stiffness of Hypertensive Subjects: Role of Nocturnal Dipping of Blood Pres…

2018

BACKGROUND: Ambulatory Arterial Stiffness Index (AASI) has been proposed as an indirect and simpler method to estimate the Arterial Stiffness (AS). AASI, calculated from a set of data collected during a 24-hours ambulatory blood pressure monitoring (ABPM), is defined as 1 minus the regression slope of diastolic on systolic blood pressure (BP) values. For a given increase in diastolic BP, the increase in systolic BP is smaller in a compliant compared to a stiff artery; the stiffer the arterial tree, the closer AASI is to 1. AASI was demonstrated to predict cardiovascular mortality, cerebrovascular events and to be associated with target organ damage. Taking into account the almost complete a…

AdultMalemedicine.medical_specialtyAmbulatory blood pressureTime Factorsnocturnal dippingAmbulatory Arterial Stiffness Index (AASI)night/day blood pressure ratioPopulationDiastoleBlood PressureComorbidity030204 cardiovascular system & hematologyEssential hypertension03 medical and health sciences0302 clinical medicineVascular StiffnessPredictive Value of TestsRisk FactorsInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineeducationAgededucation.field_of_studybiologyDipperbusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedbiology.organism_classificationmedicine.diseaseCircadian RhythmBlood pressureItalyCardiologyArterial stiffnessFemaleEssential HypertensionbusinessBody mass indexCurrent hypertension reviews
researchProduct

Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.

2013

The objective of the present study was to assess the regression of left ventricular hypertrophy (LVH) during antihypertensive treatment, and its relationship with the changes in microalbuminuria.One hundred and sixty-eight previously untreated patients with echocardiographic LVH, 46 (27%) with microalbuminuria, were followed during a median period of 13 months (range 6-23 months) and treated with lifestyle changes and antihypertensive drugs. Twenty-four-hour ambulatory blood pressure monitoring, echocardiography and urinary albumin excretion were assessed at the beginning and at the end of the study period.Left ventricular mass index (LVMI) was reduced from 137 [interquartile interval (IQI)…

AdultMalemedicine.medical_specialtyAngiotensin receptorAmbulatory blood pressurePhysiologyHeart VentriclesBlood PressureLeft ventricular hypertrophyExcretionInterquartile rangeRisk FactorsInternal medicineAlbuminsInternal MedicineMedicineAlbuminuriaHumanscardiovascular diseasesAntihypertensive Agentsbusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseRegressionBlood pressureTreatment OutcomeEchocardiographyHypertensionCardiologyMicroalbuminuriaFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateJournal of hypertension
researchProduct

Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic sy…

2010

Summary Background & aims Phytosterols (PS) lower LDLc, but their effect on metabolic syndrome (MetS) remains unknown. We evaluated whether low-fat milk enriched with PS improves cardiovascular risk factors in these patients. Methods A randomised parallel trial employing 24 moderate-hypercholesterolaemic MetS patients and consisting of two 3-month intervention phases. After a 3-month healthy diet, patients were divided into two intervention groups: diet (n = 10) and diet + PS (n = 14) (2 g/day). A control group of 24 moderate-hypercholesterolaemic patients without MetS (matched in age and BMI) underwent the same procedure. Results Neither dietary intervention nor enrichment of PS induced an…

AdultMalemedicine.medical_specialtyApolipoprotein BHomocysteineLipoproteinsHypercholesterolemiaPopulationCritical Care and Intensive Care MedicineSeverity of Illness IndexCholesterol Dietarychemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumanseducationHypolipidemic AgentsMetabolic Syndromeeducation.field_of_studyNutrition and Dieteticsmedicine.diagnostic_testbiologybusiness.industryAnticholesteremic AgentsPhytosterolsMiddle Agedmedicine.diseaseSitosterolsCholesterolEndocrinologyIntestinal AbsorptionchemistryCardiovascular DiseasesSpainDietary SupplementsIntestinal cholesterol absorptionbiology.proteinFemaleMetabolic syndromebusinessLipid profileBody mass indexLipoproteinClinical Nutrition
researchProduct

High Plasma Phospholipid Transfer Protein Levels as a Risk Factor for Coronary Artery Disease

2003

Objective— Plasma phospholipid transfer protein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Animal studies have shown that it is closely related to the development of atherosclerosis. PLTP-deficient mice have demonstrated increased antioxidation potential as well as a decrease in apolipoprotein B secretion and atherosclerotic lesions. In humans, high PLTP is associated with type II diabetes and obesity. Methods and Results— To assess the relationship between PLTP activity and coronary artery disease (CAD), a novel, high-throughput method to measure plasma PLTP activity was used, relating it to CAD in 1102 cases and 444 controls. This demo…

AdultMalemedicine.medical_specialtyApolipoprotein BLipoproteinsMyocardial InfarctionCoronary Artery DiseaseAngina PectorisAnginaCoronary artery diseaseReference ValuesRisk FactorsPhospholipid transfer proteinInternal medicinemedicineHumansAngina UnstablePhospholipid Transfer ProteinsRisk factorPhospholipidsAgedbiologybusiness.industryCase-control studyMembrane ProteinsBiological activityMiddle Agedmedicine.diseaseLogistic ModelsEndocrinologyCase-Control Studiesbiology.proteinFemaleAnimal studiesCarrier ProteinsCardiology and Cardiovascular MedicinebusinessArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

LDL size: does it matter?

2004

The atherogenic lipoprotein phenotype is characterised by a moderate increase in plasma triglycerides, a decrease in high density lipoprotein cholesterol and the prevalence of smaller denser low density lipoprotein particles. The prevalence of this partially inheritable phenotype is approximately 30% and is a feature of the metabolic syndrome associated with an increased risk for cardiovascular events. The predominance of small dense LDL has been accepted as an emerging cardiovascular risk factor by the adult treatment panel (ATP) III.

AdultMalemedicine.medical_specialtyArteriosclerosisCoronary DiseaseCohort Studieschemistry.chemical_compoundHigh-density lipoproteinSex FactorsRisk FactorsInternal medicineDiabetes mellitusmedicineDiabetes MellitusPrevalenceAnimalsHumansatherogenic lipoprotein phenotypeProspective Studiescoronary heart diseaseRisk factorsmall dense LDLTriglyceridesAgedHypolipidemic AgentsMetabolic SyndromeClinical Trials as Topicdiabetesbusiness.industryCholesterolSmokingAge FactorsGeneral MedicineCholesterol LDLAtherogenic lipoprotein phenotypeMiddle Agedmedicine.diseasePhenotypeLipoproteins LDLEndocrinologyLogistic ModelsPhenotypechemistryLow-density lipoproteinFemaleMetabolic syndromeInsulin ResistancebusinessSwiss medical weekly
researchProduct

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targ…

2006

BACKGROUND: Despite the prognostic value of metabolic syndrome for predicting cardiovascular events, few trials have investigated the effects of statin therapy on cardiovascular morbidity and mortality in patients with the metabolic syndrome. Our post hoc analysis of the Treating to New Targets (TNT) study assessed whether intensive lowering of low-density lipoprotein cholesterol with high-dose atorvastatin therapy results in cardiovascular benefits for patients with both coronary heart disease and the metabolic syndrome. METHODS: The TNT study was a prospective, double blind, parallel-group trial done at 256 sites in 14 countries between April, 1998, and August, 2004, with a median follow-…

AdultMalemedicine.medical_specialtyAtorvastatinCoronary Diseaselaw.inventionDiabetes Complicationschemistry.chemical_compoundDouble-Blind MethodRandomized controlled trialRisk FactorslawInternal medicineDiabetes mellitusAtorvastatinmedicineHumansPyrrolesMyocardial infarctionStrokeAgedMetabolic SyndromeDose-Response Relationship Drugbusiness.industryCholesterolAnticholesteremic AgentsHazard ratioCholesterol LDLGeneral MedicineMiddle Agedmedicine.diseaseSurgerychemistryCardiovascular DiseasesHeptanoic AcidsCardiologyFemaleMetabolic syndromebusinessmedicine.drug
researchProduct

Differences in hand and foot psychomotor speed among 18 pairs of monozygotic twins discordant for lifelong vehicular driving.

1997

The purpose of this study was to examine driving as a determinant of hand and foot psychomotor reaction times. Visual simple and choice hand and foot psychomotor reaction times were measured. The occupational driving contrast was determined by an interview reviewing every job held during each subject's lifetime. Comparison was made of psychomotor speed among 18 pairs of 39- to 62-year-old monozygotic male twins discordant for lifelong occupational driving. The mean discordance was the equivalent of 16 years of full-time driving. The twins who drove more tended to have slower hand simple and choice reaction times, although only the difference in hand-choice decision time was statistically si…

AdultMalemedicine.medical_specialtyAutomobile Drivingmedia_common.quotation_subjectMonozygotic twinPoison controlAudiologyVibrationRisk FactorsOccupational ExposureReaction TimeMedicineHumansMotor skillFinlandmedia_commonPsychomotor learningbusiness.industryPublic Health Environmental and Occupational HealthBody movementTwins MonozygoticMiddle AgedTwin studyLateralitybusinessPsychomotor PerformanceVigilance (psychology)International archives of occupational and environmental health
researchProduct

Coexistence of thrombophilic gene polymorphisms among 559 unrelated consecutive patients with a history of thrombosis.

2001

AdultMalemedicine.medical_specialtyBiologyGastroenterologyGenetic determinismPolymorphism (computer science)Risk FactorsInternal medicineFactor V LeidenmedicineHumansThrombophiliaGeneMethylenetetrahydrofolate Reductase (NADPH2)GeneticsVenous ThrombosisOxidoreductases Acting on CH-NH Group DonorsPolymorphism GeneticVascular diseaseFactor VThrombosisHematologyMiddle Agedmedicine.diseaseThrombosisCase-Control StudiesFemaleProthrombinThrombosis research
researchProduct

Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study.

2020

Aim We aimed to identify whether lifetime cocaine use is a risk factor for conversion from major depressive disorder (MDD) to bipolar disorder (BD) in an outpatient sample of adults. Methods This prospective cohort study included 585 subjects aged 18 to 60 years who had been diagnosed with MDD as assessed by the Mini International Neuropsychiatric Interview (MINI-Plus) at baseline (2012-2015). Subjects were reassessed a mean of 3 years later (2017-2018) for potential conversion to BD as assessed by the MINI-Plus. Lifetime cocaine use was assessed using the Alcohol, Smoking, and Substance Involvement Screening Test. Results In the second wave, we had 117 (20%) losses, and 468 patients were r…

AdultMalemedicine.medical_specialtyBipolar DisorderAdolescentPoison control03 medical and health sciencesCocaine-Related DisordersYoung Adult0302 clinical medicineRisk FactorsInternal medicinemedicineHumansBipolar disorderProspective StudiesRisk factorProspective cohort studyMini-international neuropsychiatric interviewDepressive Disorder Majorbusiness.industryGeneral NeuroscienceGeneral MedicineMiddle Agedmedicine.diseaseConfidence interval030227 psychiatryPsychiatry and Mental healthNeurologyCohortDisease ProgressionMajor depressive disorderFemaleNeurology (clinical)business030217 neurology & neurosurgeryPsychiatry and clinical neurosciencesReferences
researchProduct